DIANE KEAHEY: Open Payments
NPI 1912013988 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 16 payments from 11 companies in 2025. Trend: 2023 $1,361 · 2024 $642 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| PFIZER INC. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Insulet Corporation | 1 | $26 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Lilly USA, LLC | 1 | $21 |
| Antares Pharma, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: JARDIANCE, NURTEC ODT, Omnipod, CAPLYTA, XYOSTED, OTEZLA, VRAYLAR, Auvelity.
Industry payments across TX — which companies pay providers there.
